Femasys (FEMY) announces the United States Patent and Trademark Office, USPTO, issued a Notice of Allowance for U.S. Patent Application 18/443,798 further strengthening Femasys’ intellectual property position and coverage for the Company’s infertility therapeutic product FemaSeed Intratubal Insemination.
Education
About Us
Working with TipRanks
Follow Us
1